Spaarne Gasthuis deploys cloud-based software to enable primary diagnosis and expand collaboration with subspecialists across regional cancer network.
Spaarne Gasthuis, a clinical teaching hospital in the Greater Amsterdam region, has fully digitized its pathology practice using Concentriq AP-Dx software from Proscia to support AI-driven disease diagnosis and research capabilities.
The Netherlands-based hospital will use the platform for primary diagnosis and collaboration, enabling rapid case sharing with subspecialists and peers at other hospitals within the OncoNoVo+ regional cancer network, including the Netherlands Cancer Institute, which is also a Proscia customer.
“We are committed to providing highly specialized care to every patient, and that almost always starts with a precise, timely diagnosis,” says Timo van Dam, head of the pathology department at Spaarne Gasthuis, in a release. “Choosing Proscia was a decision we approached carefully, and we are confident its team will be a strategic, long-term partner.”
The open platform design allows Spaarne Gasthuis flexibility to select scanners and AI applications that align with its expansion goals. The software integrates bidirectionally with the hospital’s laboratory information system, aligning digital pathology with existing workflows to accelerate the transition from microscope-based diagnosis.
Cloud Deployment Accelerates Implementation
By deploying Concentriq AP-Dx in the cloud, the hospital aims to accelerate time-to-value and optimize total cost of ownership as operations scale. The platform supports the hospital’s pathologists in making treatment decisions for hundreds of thousands of patients annually.
“Fully digitizing its practice from day one speaks volumes about Spaarne Gasthuis’ approach to AI-driven pathology,” says David West, CEO of Proscia, in a release. “The team recognizes the value and is eager to deliver it to patients. As an academic medical center, it is also well positioned to build on this foundation to advance the scientific research it conducts.”
The implementation positions the hospital to leverage pathology images for biomedical research and AI development, as these images provide detailed views of diseases like cancer that can accelerate research and fuel diagnostic innovations.
According to Proscia, 16 of the top 20 pharmaceutical companies and a global laboratory network delivering more than 8 million diagnoses annually use the company’s solutions.
ID 154741318 © Pop Nukoonrat | Dreamstime.com
